SkinMedica™ Illuminize Peel™
Indications: Indications for Illuminize Peel include
photodamaged skin, fine lines and wrinkles and irregular pigmentation.
Description: This non-invasive superficial peel
utilizes a novel approach to chemical peeling with a newer generation
of alpha hydroxy Acids (Mandelic Acid and Malic Acid) in combination
with Phytic Acid and commonly used peeling agents (Salicylic Acid
and Resorcinol) to maximize skin rejuvenating effects with low irritation.
Purpose: The Illuminize Peel is a very superficial peel
designed to improve the texture and appearance of your skin.
Patients Who Should Not Be Treated: The Illuminize Peel
treatment SHOULD NOT be used on patients with active cold sores
or warts, skin with open wounds,sunburn, excessively sensitive skin,
dermatitis or inflammatory rosecea in the area to be treated. Inform
the esthetician if you have any history of herpes simplex. You should
also not have an Illuminize Peel treatment if you have any history
of rashes, or other skin reactions, or may be sensitive to any of
the components of this treatment. Illuminize Peel should not be
performed on patients with an allergy to salicylates (i.e. aspirin).
This peel is also not recommended if you have taken Accutane™,
or recieved chemotherapy or radiation therapy within the last year.
Illuminize Peel should not be administered to pregnant or breastfeeding
(lactating) women.
One Week Before Your Illuminize Peel: Avoid these products
and/or procedures:
Electrolysis
Waxing
Depilitory Creams
Laser Hair Removal
Botox® Injections
Three Days Before Your Illuminize Peel: Avoid these products and/or
procedures:
Retin-A®, Renova®, Differin®, Tazorac®
Any products containing retinol, AHA or BHA, or benzoyl peroxide
Any exfoliating products that may be drying or irritating
Note: The use of these products/treatments prior
to your Peel may increase skin sensitivity and cause a stronger
reaction.
Note: Patients who have had medical cosmetic facial
treatments or procedures (e.g. laser therapy, surgical procedures,
cosmetic filler, microdermabrasion, etc.) should wait until skin
sensitivity completely resolves before having the Illuminize Peel
Procedure.
After Your Illuminize Peel: It is crucial to the health of your
skin and the success of your peel that these guidelines be followed:
It is imperative to use a sunscreen with an SPF of at least 20 and
avoid direct sunlight for at least one week.
Patients with hypersensitivity the the sun should take extra precautions
to guard against sun exposure immediately following the procedure
as they may be more sensitive following the peel.
Because of the superficial nature of this peel, patients should
not expect to see visible peeling. Occasionally, some patients may
have very minor flaking 3-4 days after the procedure.
Skin may appear slightly redder than usual for about 1-2 hours after
the treatment. If neck and décolletage are treated, the redness
might last slightly longer.
Skin should look normal the next day.
When washing the face, do not scrub or use a wash cloth. Use a mild
soap-free cleanser such as SkinMedica® Facial Cleanser.
Apply SkinMedica® TNS Ceramide Treatment Cream for 4-5 days
after the peel as often as needed to relieve any dryness, followed
by a moisturizer of your choice, such as SkinMedica TNS Ultimate
Daily Moisturizer™ or Ultra Sheer Moisturizer.
The regular use of Retin-A, alpha-hydroxy acid (AHA), products or
bleaching creams con be resumed after 4-5 days.
Wait until the peeling is complete before having ANY OTHER FACIAL
PROCEDURES, including:
Facials
Microdermabrasion
Laser Treatments
Laser Hair Removal
Botox Injections
Injectable Fillers
Sunburn Alert
This product contains an alpha hydroxy acid (AHA) that may increase
your skin’s sensitivity to the sun and particularly the possibility
of sunburn. Use a sunscreen, wear protective clothing, and limit
sun exposure while using this product and for a week afterwards.
|